These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 22441428

  • 1. Dolastatin 15, a mollusk linear peptide, and Celecoxib, a selective cyclooxygenase-2 inhibitor, prevent preneoplastic colonic lesions and induce apoptosis through inhibition of the regulatory transcription factor NF-κB and an inflammatory protein, iNOS.
    Piplani H, Vaish V, Sanyal SN.
    Eur J Cancer Prev; 2012 Nov; 21(6):511-22. PubMed ID: 22441428
    [Abstract] [Full Text] [Related]

  • 2. Up-regulation of p53 and mitochondrial signaling pathway in apoptosis by a combination of COX-2 inhibitor, Celecoxib and Dolastatin 15, a marine mollusk linear peptide in experimental colon carcinogenesis.
    Piplani H, Vaish V, Rana C, Sanyal SN.
    Mol Carcinog; 2013 Nov; 52(11):845-58. PubMed ID: 22623379
    [Abstract] [Full Text] [Related]

  • 3. Modulation of inflammatory changes in early stages of colon cancer through activation of PPARgamma by diclofenac.
    Kaur J, Sanyal SN.
    Eur J Cancer Prev; 2010 Sep; 19(5):319-27. PubMed ID: 20485182
    [Abstract] [Full Text] [Related]

  • 4. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS.
    Cancer Res; 2002 Jan 01; 62(1):165-70. PubMed ID: 11782374
    [Abstract] [Full Text] [Related]

  • 5. Dolastatin, along with Celecoxib, stimulates apoptosis by a mechanism involving oxidative stress, membrane potential change and PI3-K/AKT pathway down regulation.
    Piplani H, Rana C, Vaish V, Vaiphei K, Sanyal SN.
    Biochim Biophys Acta; 2013 Nov 01; 1830(11):5142-56. PubMed ID: 23872169
    [Abstract] [Full Text] [Related]

  • 6. Dolastatin 15 and its emerging antineoplastic effects.
    Kapoor SS.
    Eur J Cancer Prev; 2013 Sep 01; 22(5):486-7. PubMed ID: 23900223
    [No Abstract] [Full Text] [Related]

  • 7. Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappaB, iNOS, COX-2, TNF-alpha, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis.
    Umesalma S, Sudhandiran G.
    Basic Clin Pharmacol Toxicol; 2010 Aug 01; 107(2):650-5. PubMed ID: 20406206
    [Abstract] [Full Text] [Related]

  • 8. Angiostatic properties of sulindac and celecoxib in the experimentally induced inflammatory colorectal cancer.
    Vaish V, Piplani H, Rana C, Sanyal SN.
    Cell Biochem Biophys; 2013 Jun 01; 66(2):205-27. PubMed ID: 23149858
    [Abstract] [Full Text] [Related]

  • 9. Sulindac and Celecoxib regulate cell cycle progression by p53/p21 up regulation to induce apoptosis during initial stages of experimental colorectal cancer.
    Vaish V, Rana C, Piplani H, Vaiphei K, Sanyal SN.
    Cell Biochem Biophys; 2014 Mar 01; 68(2):301-19. PubMed ID: 23857431
    [Abstract] [Full Text] [Related]

  • 10. Effect of etoricoxib, a cyclooxygenase-2 selective inhibitor on aberrant crypt formation and apoptosis in 1,2 dimethyl hydrazine induced colon carcinogenesis in rat model.
    Sharma P, Kaur J, Sanyal SN.
    Nutr Hosp; 2010 Mar 01; 25(1):39-48. PubMed ID: 20204254
    [Abstract] [Full Text] [Related]

  • 11. Activation of NF-κB: bridging the gap between inflammation and cancer in colitis-mediated colon carcinogenesis.
    Setia S, Nehru B, Sanyal SN.
    Biomed Pharmacother; 2014 Feb 01; 68(1):119-28. PubMed ID: 24269000
    [Abstract] [Full Text] [Related]

  • 12. Role of cytokines and Jak3/Stat3 signaling in the 1,2-dimethylhydrazine dihydrochloride-induced rat model of colon carcinogenesis: early target in the anticancer strategy.
    Saini MK, Vaish V, Sanyal SN.
    Eur J Cancer Prev; 2013 May 01; 22(3):215-28. PubMed ID: 23514809
    [Abstract] [Full Text] [Related]

  • 13. Induction of apoptosis as a potential chemopreventive effect of dual cycloxygenase inhibitor, diclofenac, in early colon carcinogenesis.
    Sanyal SN, Kaur J.
    J Environ Pathol Toxicol Oncol; 2010 May 01; 29(1):41-53. PubMed ID: 20528746
    [Abstract] [Full Text] [Related]

  • 14. Chemopreventive efficacy of green tea drinking against 1,2-dimethyl hydrazine-induced rat colon carcinogenesis.
    Sadik NA.
    Cell Biochem Funct; 2013 Apr 01; 31(3):196-207. PubMed ID: 23008118
    [Abstract] [Full Text] [Related]

  • 15. Chemoprevention of 1,2-dimethylhydrazine-induced colon carcinogenesis by a non-steroidal anti-inflammatory drug, etoricoxib, in rats: inhibition of nuclear factor kappaB.
    Tanwar L, Vaish V, Sanyal SN.
    Asian Pac J Cancer Prev; 2009 Apr 01; 10(6):1141-6. PubMed ID: 20192600
    [Abstract] [Full Text] [Related]

  • 16. Protective effects of vanadium against DMH-induced genotoxicity and carcinogenesis in rat colon: removal of O(6)-methylguanine DNA adducts, p53 expression, inducible nitric oxide synthase downregulation and apoptotic induction.
    Samanta S, Swamy V, Suresh D, Rajkumar M, Rana B, Rana A, Chatterjee M.
    Mutat Res; 2008 Feb 29; 650(2):123-31. PubMed ID: 18155637
    [Abstract] [Full Text] [Related]

  • 17. Coenzyme Q10 attenuated DMH-induced precancerous lesions in SD rats.
    Kim JM, Park E.
    J Nutr Sci Vitaminol (Tokyo); 2010 Feb 29; 56(2):139-44. PubMed ID: 20495296
    [Abstract] [Full Text] [Related]

  • 18. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
    Tang BD, Zeng ZR, Hu PJ.
    Ai Zheng; 2006 Oct 29; 25(10):1205-9. PubMed ID: 17059761
    [Abstract] [Full Text] [Related]

  • 19. Anti-proliferative and apoptotic effects of etoricoxib, a selective COX-2 inhibitor, on 1,2-dimethylhydrazine dihydrochloride-induced colon carcinogenesis.
    Tanwar L, Piplani H, Sanyal S.
    Asian Pac J Cancer Prev; 2010 Oct 29; 11(5):1329-33. PubMed ID: 21198287
    [Abstract] [Full Text] [Related]

  • 20. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV.
    Cancer Res; 2000 Jan 15; 60(2):293-7. PubMed ID: 10667579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.